Proteome Sciences (LON:PRM) Shares Down 9.8% – Time to Sell?

by · The Markets Daily

Proteome Sciences plc (LON:PRM – Get Free Report)’s stock price traded down 9.8% during mid-day trading on Wednesday . The company traded as low as GBX 3.18 ($0.04) and last traded at GBX 3.18 ($0.04). 41,420 shares changed hands during mid-day trading, a decline of 55% from the average session volume of 91,685 shares. The stock had previously closed at GBX 3.52 ($0.04).

Proteome Sciences Stock Up 40.4 %

The firm has a 50 day simple moving average of GBX 2.92 and a two-hundred day simple moving average of GBX 3.11. The stock has a market capitalization of £14.17 million, a P/E ratio of -480.00 and a beta of 0.07.

About Proteome Sciences

(Get Free Report)

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.

Featured Articles